Kidney Cancer
FEATURES
avatar
1343 clinical trials
avatar
224 cell line models
avatar
19 approved drugs
IMAGE
Kidney Cancer
Molecular Synopsis
OVERVIEW
Drugs and clinical candidates

19 drugs have received FDA approval for Kidney Cancer:

  • Aldesleukin
  • Amifostine
  • Axitinib
  • Bevacizumab
  • Cabozantinib-S-Malate
More

252 drugs have a clinical trial registered for Kidney Cancer.

2896 compounds have been tested in Kidney Cancer (1984 <= 500nM potency).

Sources: cancer.gov, clinicaltrials.gov, ChEMBL.

Clinical trials
There are 1343 clinical trials for Kidney Cancer, 881 of which have one or more drug interventions, 462 with no drug intervention.
Cell line models

There are 224 Cell Line Models for Kidney Cancer.

Source: COSMIC
Cell line models

Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from clinicaltrials.gov mesh condition terms to Kidney Cancer:
  • Adrenal Gland Neoplasms
  • Wilms Tumor
  • Adrenal Cortex Neoplasms
  • Kidney Neoplasms
  • Carcinoma, Renal Cell
The following terms have been mapped from cancer.gov to Kidney Cancer:
  • Renal cell carcinoma (a type of kidney cancer) that is advanced. It is used with axitinib as first-line therapy.????
  • With ipilimumab in some patients with renal cell carcinoma that has not been treated
  • Renal cell carcinoma (a type of kidney cancer) that is advanced
  • Wilms tumor
  • Renal cell carcinoma (a type of kidney cancer) that is advanced. It is used:In patients who have already received angiogenesis inhibitor therapy
More